Bionomics Limited   Report issue

For profit Phase 1 Phase 2
Founded: Therbarton Australia (1999)

Organization Overview

First Clinical Trial
2010
NCT01034631
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bionomics Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Colorectal Neoplasms (Phase 1)

Hypersensitivity (Phase 2)

Ovarian Neoplasms (Phase 2)

Psychomotor Agitation (Phase 2)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 9